Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hans Blokzijl"'
Autor:
Thijs J W van de Laar, Bert C Baak, Bart van Hoek, Joop E. Arends, Hans Blokzijl, Marc van der Valk, Richard Molenkamp, Cas J. Isfordink, Marjolein Knoester, Els Wessels, Sylvia M Brakenhoff, Cees van Nieuwkoop, Sjoerd Rebers, Janke Schinkel
Publikováno v:
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 8(2). OXFORD UNIV PRESS INC
Open forum infectious diseases, 8(2):ofab006. Oxford University Press
Open Forum Infectious Diseases, 8(2):ofab006. Oxford University Press
Open Forum Infectious Diseases, 8(2). OXFORD UNIV PRESS INC
Open forum infectious diseases, 8(2):ofab006. Oxford University Press
Open Forum Infectious Diseases, 8(2):ofab006. Oxford University Press
Background The majority of hepatitis C virus (HCV) infections are found in low- and middle-income countries, which harbor many region-specific HCV subtypes. Nevertheless, direct-acting antiviral (DAA) trials have almost exclusively been conducted in
Autor:
Stefan P Berger, Martijn Bakker, Lambert F.R. Span, Tjip S. van der Werf, Anne-Grete Märtson, Marieke G G Sturkenboom, Daan J Touw, Marjolein Knoester, Hans Blokzijl, Jan-Willem C. Alffenaar, Kevin Damman, Erik A M Verschuuren
Publikováno v:
Open Forum Infectious Diseases
Background Oral valganciclovir and intravenous ganciclovir are used for prophylaxis, treatment, and pre-emptive treatment of cytomegalovirus and human herpesvirus 6. It is important to estimate the exposure to these antivirals, as deviating levels ca
Autor:
Hans Blokzijl, Jan-Stephan F. Sanders, Erik A M Verschuuren, Annelies Riezebos-Brilman, Bert Niesters
Publikováno v:
Open Forum Infectious Diseases. 2